Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Outcome measurement
Ask a
question
Favorite
The main outcome assessed was complete repose (CR) to NEPA. CR was defined as no emesis or no requirement of rescue medication. CR was determined in acute phase (0-24 h), delayed phase (24-120 h) and in overall phase (0-120 h). Overall CR was primary outcome measure. Effect of study drug was also evaluated by emetogenicity of chemotherapy as high and moderate as well as in by the cycle of chemotherapy.
Copyright and License information: ©2020 The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
